Trial Profile
A Double blind, Randomized, Placebo-controlled Tolcapone-Enhanced Neurocognition in Healthy Adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Oct 2017
Price :
$35
*
At a glance
- Drugs Tolcapone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 19 Oct 2017 New trial record